Zimmer Biomet Holdings, Inc.Zimmer Biomet Holdings, Inc.Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

No trades
See on Supercharts
Market capitalization
‪24.88 B‬USD
‪1.02 B‬USD
‪7.39 B‬USD
‪204.81 M‬
Beta (1Y)
1.06

About Zimmer Biomet Holdings, Inc.

CEO
Ivan Tornos
Headquarters
Warsaw
Employees (FY)
‪18 K‬
Founded
1927
ISIN
US98956P1021
FIGI
BBG000BKPL53
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ZBH is 121.30 USD — it has decreased by 0.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Zimmer Biomet Holdings, Inc. stocks are traded under the ticker ZBH.
Zimmer Biomet Holdings, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Zimmer Biomet Holdings, Inc. has a max estimate of 160.00 USD and a min estimate of 109.00 USD.
ZBH earnings for the last quarter are 1.65 USD whereas the estimation was 1.60 USD which accounts for 3.27% surprise. Estimated earnings for the next quarter are 2.15 USD. See more details about Zimmer Biomet Holdings, Inc. earnings.
Zimmer Biomet Holdings, Inc. revenue for the last quarter amounts to ‪1.75 B‬ USD despite the estimated figure of ‪1.75 B‬ USD. In the next quarter revenue is expected to reach ‪1.93 B‬ USD.
Yes, you can track Zimmer Biomet Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
ZBH stock has fallen by 5.09% compared to the previous week, the month change is a 3.17% fall, over the last year Zimmer Biomet Holdings, Inc. has showed a 9.46% decrease.
Like other stocks, ZBH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zimmer Biomet Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ZBH reached its all-time high on Apr 29, 2021 with the price of 174.97 USD, and its all-time low was 23.96 USD and was reached on Sep 18, 2001.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is Zimmer Biomet Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zimmer Biomet Holdings, Inc. EBITDA is ‪2.33 B‬ USD, and current EBITDA margin is 31.63%. See more stats in Zimmer Biomet Holdings, Inc. financial statements.